MilliporeSigma Brochures and Guides
-
The Device Of Choice For Applications Requiring Higher Yield
10/16/2025
High-flux membranes enable scalable filtration of biologics even under harsh conditions. Ideal for high-viscosity feeds, these cassettes support efficient processing and reliable cleanability.
-
Regionalized Filter Supply Chain: Biopharma Supply, Reimagined
10/16/2025
Discover a regionalized filtration network that delivers consistency, security, and sustainability for biopharma manufacturing—featuring ISO-certified sites, climate-neutral operations, and a broad filter portfolio.
-
Achieve Higher Targeted Concentrations
9/30/2025
High-concentration protein therapies offer patient and clinician benefits, but processing them introduces pressure-related challenges. Learn more about how pressure impacts final concentration outcomes.
-
Keep A Close Eye On Quality With Excipients For Drug Formulation
8/27/2025
Developing ophthalmic drugs demands precision and compliance. Explore a specialized excipient portfolio that supports optimal formulation to enhance stability, sterility, and patient comfort.
-
Addressing Your Requirements For Parenteral Applications
8/27/2025
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Granulated Materials: Easy Handling For Improved Process Efficiency
8/11/2025
Granulated raw materials streamline manufacturing by reducing caking, dust, and manual weighing. Boost efficiency and safety by discovering how this switch can transform buffer preparation.
-
A High-Purity Excipient Suitable For High-Risk Vaccine Applications
7/21/2025
Examine an ultra-pure, sustainable alternative to shark-derived squalene. With ≥99% purity, it ensures safety, consistency, and ethical sourcing for innovation.
-
An Alternative Suitable For High-Risk Applications
7/21/2025
Squalene, a natural lipid from plants and sharks, enhances vaccine effectiveness through nanoemulsion-based adjuvants. Explore more about its vital role in modern immunology innovation.
-
AAV Production: Your AAV CDMO Partner, Every Batch, Every Milestone
6/17/2025
Confidently navigate every stage of development with tailored tech transfer solutions backed by AAV expertise. Discover how to de-risk, scale, and optimize your process for high-quality performance.
-
Unlock Amorphous Solubility Enhancement For Challenging Compounds
6/5/2025
Enhance drug solubility and bioavailability with an advanced mesoporous silica excipient that stabilizes poorly soluble compounds in their amorphous form and is backed by strong regulatory and quality support.